Supplementation in Tennis

Supplementation in Tennis: an Observational Study

The aim of this observational study is to examine supplementation (e.g. caffeine or creatin) use in both male and female professional tennis players.

Study Overview

• Status: Unknown
• Conditions: Nutrition; Supplements; Tennis

• Study Type: Observational
• Enrollment (Anticipated): 200

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

The participants will have to be professional tennis players, both male and female.

Description

Inclusion Criteria:

• Professional tennis player

Exclusion Criteria:

• Any metabolic disease or a possible pregnancy

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Tennis players

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Supplementation questionnaire	The participants will be asked about their supplementation use using a questionnaire. Participants will have a list of possible supplements on this questionnaire and they will be asked to indicate which supplement they take on a regular basis (at least once every three months). The primary outcome measure will be the frequency (as a percentage) of the supplement intake.	October 2017 - September 2018

Collaborators and Investigators

• Sponsor: Vrije Universiteit Brussel

Study record dates

Study Major Dates

• Study Start (Anticipated): October 1, 2017
• Primary Completion (Anticipated): September 30, 2018
• Study Completion (Anticipated): March 1, 2019

Study Registration Dates

• First Submitted: July 25, 2017
• First Submitted That Met QC Criteria: July 25, 2017
• First Posted (Actual): July 27, 2017

Study Record Updates

• Last Update Posted (Actual): July 27, 2017
• Last Update Submitted That Met QC Criteria: July 25, 2017
• Last Verified: July 1, 2017

More Information

Terms related to this study

• Other Study ID Numbers: Suppl Tennis

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Individual participant data will not be shared with other researchers.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No